Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective.
Khushbu J PatelDavid YangHoward H FeldmanGing-Yuek Robin HsiungHaakon Berge NygaardJohn R BestEmily DwoshJulie M RobillardMari L DeMarcoPublished in: Alzheimer's & dementia (New York, N. Y.) (2024)
Perspectives of persons with lived experience in dementia provide new insight into the value of biomarker testing and should be included as part of evidence-guided considerations for pre-test counseling and result disclosure. Moreover, study findings identify an interval when patients and care partners are highly receptive to positive lifestyle and medical interventions.
Keyphrases
- healthcare
- end stage renal disease
- physical activity
- hiv testing
- chronic kidney disease
- ejection fraction
- newly diagnosed
- quality improvement
- cardiovascular disease
- mild cognitive impairment
- cognitive decline
- pain management
- type diabetes
- weight loss
- cognitive impairment
- men who have sex with men
- affordable care act
- hepatitis c virus
- chronic pain
- hiv infected